"When Less is More": Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer

Area of Science:

• Oncology
• Radiation Oncology
• Breast Cancer Treatment

Background:

• Traditional early-stage breast cancer treatment involved lumpectomy, endocrine therapy, and 3-5 weeks of whole-breast radiation.
• Recent data, particularly since 2019, indicates significant shifts in radiation treatment paradigms.

Purpose of the Study:

• To review modern clinical trials and advancements in radiation therapy for early-stage breast cancer.
• To highlight changes in radiation treatment paradigms driven by recent research.
• To emphasize the move towards personalized, patient-centered care in oncology.

Main Methods:

• Review of modern clinical trials and data published since 2019.
• Analysis of ultra-hypofractionated regimens and partial breast irradiation.
• Evaluation of evidence supporting omission of radiation for select low-risk patients.

Main Results:

• Ultra-hypofractionated regimens allow total radiation doses in as few as 5 treatments over 1 week for eligible patients.
• Partial breast irradiation is an effective and well-tolerated alternative treatment.
• Evidence supports omitting radiation for certain older adults with low-risk breast cancer.

Conclusions:

• Advancements in radiation oncology provide tools for tailored treatment plans based on individual patient risks and toxicity concerns.
• Ongoing research focuses on precision cancer care, treatment de-escalation, and toxicity management.
• Shared decision-making is crucial for balancing treatment efficacy, toxicity, and quality of life, aiming for personalized cancer care.